feed,title,long_url,short_url
ğŸ”MarketWatch,U.S. stocks open higher after employment report shows wage growth cooling,http://www.marketwatch.com/news/story/us-stocks-open-higher-after/story.aspx?guid=%7B7563C6E6%2DAC89%2D4291%2D8E63%2DC5ABF8D8B120%7D&siteid=rss,https://da.gd/DdIeNi
ğŸ”MarketWatch,Traders raise chances of quarter-of-a-percentage-point Fed rate hikes in February and March after December jobs report,http://www.marketwatch.com/news/story/traders-raise-chances-quarter-of-a-percentage-point-fed/story.aspx?guid=%7BF0547361%2DA979%2D4C7B%2DBA4D%2D03D5CF2EC314%7D&siteid=rss,https://da.gd/Q28yBV
ğŸ”MarketWatch,Comcast elevates Jason Armstrong to CFO,http://www.marketwatch.com/news/story/comcast-elevates-jason-armstrong-cfo/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7177%2DD880732438A5%7D&siteid=rss,https://da.gd/7wX0ev
ğŸ”MarketWatch,Silvergate Capital stock falls another 8.5%; JPMorgan downgrades company to neutral,http://www.marketwatch.com/news/story/silvergate-capital-stock-falls-another/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7177%2DD14C2DB347A8%7D&siteid=rss,https://da.gd/P7ObXd
ğŸ”MarketWatch,Atai says its depression treatment failed in a mid-stage clinical trial,http://www.marketwatch.com/news/story/atai-says-its-depression-treatment/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7177%2DD09F3CAA7CC8%7D&siteid=rss,https://da.gd/nFPtY
ğŸ”MarketWatch,Fate Therapeutics stocks heads for record selloff after Janssen collaboration terminated and job cuts,http://www.marketwatch.com/news/story/fate-therapeutics-stocks-heads-record/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7177%2DCFBAF7BE20EC%7D&siteid=rss,https://da.gd/WivT8
ğŸ”MarketWatch,Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China,http://www.marketwatch.com/news/story/casi-pharmaceuticals-run-clinical-trial/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7177%2DCE56FB16EE17%7D&siteid=rss,https://da.gd/9xW9P
